[Federal Register Volume 67, Number 15 (Wednesday, January 23, 2002)]
[Notices]
[Page 3168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-1643]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Method and Kit for Detection of 
Dengue Virus

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 6,190,859 entitled 
``Method and Kit for Detection of Dengue Virus'' issued 02/20/01. This 
patent has been assigned to the United States Government as represented 
by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: An inactivated dengue virus vaccine to 
immunize and protect humans against dengue fever is described. The 
vaccine is based on dengue viruses which have been propagated to high 
titers in suitable cells, purified and inactivated under conditions 
which destroy infectivity but preserve immunogenicity, a high level of 
which is demonstrated in animal models. Uses of the inactivated dengue 
virus for detecting antibodies to dengue and kits therefore are also 
described.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-1643 Filed 1-22-02; 8:45 am]
BILLING CODE 3710-08-M